WebExelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. CEO Michael M. Morrissey Employees 1,223 Headquarters Alameda, California Founded 1994 EXEL Key Statistics Market cap 6.64B Web10 feb. 2024 · View EXEL: Exelixisinvestment & stock information. Get the latest EXEL: Exelixis detailed stock quotes, stock data, Real-Time ECN, charts, stats and more..
Hormonal Therapy Market Size with Modern Trends, In 2024 ... - MarketWatch
Web4 apr. 2024 · Hedge fund Farallon Capital Management plans to launch a proxy fight at cancer-drug maker Exelixis Inc. EXEL, +0.36%, and has nominated three directors to … WebEXEL U.S.: Nasdaq Exelixis Inc. Watch list Create EXEL Alert After Hours Last Updated: Sep 30, 2024 7:01 p.m. EDT Delayed quote $ 15.70 0.02 0.13% After Hours Volume: … d1 girls soccer colleges
EXEL - Exelixis Inc Stock News - NASDAQ Morningstar
Web3 mrt. 2024 · It has been updated. Exelixis Inc. EXEL, +0.11% shares fell in the extended session Thursday after the biotech drug maker said a late-stage clinical study testing its … WebExelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include … JNJ Complete Johnson & Johnson stock news by MarketWatch. View real-time … Exelixis Inc. advanced stock charts by MarketWatch. View EXEL historial stock … Exelixis Inc. analyst estimates, including EXEL earnings per share estimates and … Exelixis Inc. company facts, information and financial ratios from MarketWatch. Exelixis Inc. SEC filings breakout by MarketWatch. View the EXEL U.S. … Web8 sep. 2024 · Exelixis reported earnings of 22 cents in the second quarter of 2024, beating the Zacks Consensus Estimate of 20 cents. In the year-ago quarter, EXEL reported earnings of 30 cents per share.... bingle groups